Pacira BioSciences, Inc.
Summary
This filing is NOT a Rule 506(b) or 506(c) Form D for capital raising. It is a Form DEFA14A — a notice regarding a definitive proxy material filing by Pacira BioSciences, Inc. (ticker: PCRX), a publicly traded company. No new capital was raised via this filing; the $65.0M figure appears to be a data entry error and does not represent proceeds from a private placement.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Full Analysis
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Dare Bioscience, Inc.
Uniform Bio Inc.
Matthias Therapeutics, LLC
Anika Therapeutics, Inc.
DEF 14A - Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc.
Strategy Inc
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Promoting Advanced Artificial Intelligence Innovation and Security
This executive order directs multiple federal agencies to prioritize cybersecurity hardening of national security, Department of War, and civilian government systems within 30 days. It establishes a classified benchmarking process for 'covered frontier models' and a voluntary framework for AI developers to provide early access to such models to the government for cybersecurity purposes. It also creates an AI cybersecurity clearinghouse, expands cybersecurity hiring pathways, and directs enforcement against AI-enabled computer crimes.
Approving Critical Position Pay Authority for National Security Investment Workforce
This memorandum authorizes the Office of Personnel Management to allocate up to 400 critical positions with pay up to $400,000 to recruit specialized talent for national security investment programs, focusing on critical minerals, advanced materials, and strategic supply chains. It directs OPM and OMB to oversee allocation and ensure pay is used only to recruit or retain exceptionally qualified individuals. The action aims to accelerate domestic mineral production and reduce foreign dependence.
Integrating Financial Technology Innovation into Regulatory Frameworks
This executive order directs federal financial regulators to review and streamline regulations that hinder fintech innovation, particularly for small and emerging firms, and requests the Federal Reserve to evaluate expanding access to its payment accounts and services for non-bank and digital asset firms. It aims to reduce barriers to entry and encourage partnerships between fintech firms and traditional financial institutions, with specific deadlines for reviews and reports.